Quick Answer
Roivant Sciences Ltd. reported Cash And Cash Equivalents At Carrying Value of $2.72 billion for the year ending 2025.
- Roivant Sciences Ltd. showed a decrease of -58.2% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Roivant Sciences Ltd.'s annual report (Form 10-K), filed with the SEC on May 29, 2025.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 5 years of available data (2021 to 2025), Roivant Sciences Ltd.'s Cash And Cash Equivalents At Carrying Value has grown by 32.1%.
- Historical annual values: Fiscal year 2025: $2.72 billion | Fiscal year 2024: $6.49 billion | Fiscal year 2023: $1.68 billion | Fiscal year 2022: $2.06 billion | Fiscal year 2021: $2.06 billion.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: